Recordati (RCDTF) Upgraded by Zacks Investment Research to “Hold”

Share on StockTwits

Recordati (OTCMKTS:RCDTF) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

According to Zacks, “Recordati S.p.A. is a pharmaceutical company. It engaged in the research, development, manufacturing and marketing of pharmaceuticals for rare disease treatments. The company operates primarily in Russia, Turkey, North Africa and United States of America. Recordati S.p.A. is headquartered in Milan, Italy. “

RCDTF stock opened at $34.70 on Thursday. The company has a market capitalization of $7.26 billion, a P/E ratio of 21.96, a P/E/G ratio of 2.50 and a beta of 0.06. Recordati has a 52 week low of $34.70 and a 52 week high of $34.87.

About Recordati

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals in Europe, the Middle East, Africa, the United States, Canada, and internationally. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, cosmetics, dermatology, dietary supplements, gynecology and obstetrics, medical devices, musculo-skeletal disorders and analgesia, over the counter/non-prescription pharmaceuticals, urology, allergy, anti-infectives, central nervous system, endocrinology, gastrointestinal, nutrition and related products, immune-suppressants, pain management/inflammation, generics, pneumology, antipyretics and cold preparations, endocrinology, oncology, respiratory, and radio contrast agent, as well as ear, nose, and throat.

Featured Story: Bear Market

Get a free copy of the Zacks research report on Recordati (RCDTF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Recordati Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Dine Brands Global Inc  Receives $121.50 Average Price Target from Analysts
Dine Brands Global Inc Receives $121.50 Average Price Target from Analysts
SelfSell Price Tops $0.0042 on Major Exchanges
SelfSell Price Tops $0.0042 on Major Exchanges
PrimeStone Hits One Day Volume of $430.00
PrimeStone Hits One Day Volume of $430.00
HBZ coin Market Cap Tops $595,151.00
HBZ coin Market Cap Tops $595,151.00
Analysts Anticipate Autohome Inc  to Announce $1.11 EPS
Analysts Anticipate Autohome Inc to Announce $1.11 EPS
Zeitcoin Price Hits $0.0000 on Major Exchanges
Zeitcoin Price Hits $0.0000 on Major Exchanges


 
© 2006-2019 Zolmax.